STERIS Prices $1.5 Billion in Senior Notes to Fund Pending Acquisition
STERIS priced $1.5 billion in senior notes, with proceeds intended in part to fund its pending acquisition of Xodus Medical.
STERIS priced $1.5 billion in senior notes, with proceeds intended in part to fund its pending acquisition of Xodus Medical.Key Highlights:Original SEC Filing: STERIS plc [ STE ] - 8-K - Nov. 12, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important informatio…